Germantown’s QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 Portfolio

Published on :

QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 Portfolio GERMANTOWN, Md. & HILDEN, Germany–(BUSINESS WIRE)– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the Emergency [….]

$2.5 Million Grant Awarded to BioHealth Capital Region Research Collaborative to Fight Deadly Virus

Published on :

$2.5 Million Grant Awarded to BioHealth Capital Region Research Collaborative to Fight Deadly Virus Scientists from across the BioHealth Capital Region will collaborate on a five-year, $2.5 million grant from [….]